Tabula Rasa HealthCare Overview
Get informed when a big investor buys or sells
+ Follow78.35%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
The latest ROE for TRHC is 78.35%. That is above the Consumer Staples sector average of 41.42%. Investors often review this figure alongside Tabula Rasa HealthCare's historical trend and sector peers before judging valuation or financial health.
Against Consumer Staples companies, TRHC currently prints 78.35% for ROE, while the sector average sits near 41.42%. That is roughly 89.2% above the sector mean. Large gaps often invite a closer look at Tabula Rasa HealthCare's growth, margins, and balance sheet.
Return on Equity shows how effectively Tabula Rasa HealthCare converts resources into returns. At 78.35%, TRHC may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting TRHC's ROE (78.35%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack Tabula Rasa HealthCare's ROE against similar Consumer Staples names. You can also browse sector and industry screens on Stockcircle for a broader set of Consumer Staples companies and their key multiples and fundamentals.
